Physician profile
Michael Saito
NPI 1912989385
$288.21
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.17 · 2020: $1.92 · 2022: $173 · 2023: $28.87 · 2024: $48.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $77.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $77.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $104.94 | 2022 | |
| Glaxosmithkline, LLC. | $43.13 | 2022 | |
| Boston Scientific Corporation | $28.87 | 2023 | Lithovue |
| Merck Sharp & Dohme LLC | $25.17 | 2024 | Vaxneuvance, Vaxelis, Gardasil |
| Neurelis, INC. | $24.83 | 2022 | |
| Verrica Pharmaceuticals INC. | $23.18 | 2024 | Ycanth |
| Ironshore Pharmaceuticals INC. | $22.78 | 2019 | |
| Travere Therapeutics, INC. | $15.31 | 2019-2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Saito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.